Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation

Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation

This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12943-020-1145-5.

Bibliographic Details
Main Authors:	Mingli Han, Yuanting Gu, Pengwei Lu, Jingyi Li, Hui Cao, Xiangke Li, Xueke Qian, Chao Yu, Yunqing Yang, Xue Yang, Na Han, Dongwei Dou, Jianguo Hu, Huaying Dong
Format:	Article
Language:	English
Published:	BMC 2022-07-01
Series:	Molecular Cancer
Online Access:	https://doi.org/10.1186/s12943-022-01610-z

Similar Items

Retraction Note: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer
by: Mingli Han, et al.
Published: (2023-11-01)

LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p
by: Dang Y, et al.
Published: (2021-06-01)

Bidirectional interaction of lncRNA AFAP1-AS1 and CRKL accelerates the proliferative and metastatic abilities of hepatocarcinoma cells
by: Sattar Abdul, et al.
Published: (2020-07-01)

Overexpression of lncRNA AFAP1-AS1 as a diagnostic biomarker in non-small cell lung cancer
by: Sajjad Ghalib Ibrahim Alnajar, et al.
Published: (2021-10-01)

Prognostic value of lncRNA AFAP1‐AS1 in breast cancer: a meta‐analysis and validated study in Chinese population
by: Zhenxing Yang, et al.
Published: (2024-01-01)

Silencing of LncRNA AFAP1-AS1 Inhibits Cell Proliferation in Oral Squamous Cancer by Suppressing CCNA2
by: Li T, et al.
Published: (2021-10-01)

A Review on the Role of AFAP1-AS1 in the Pathoetiology of Cancer
by: Soudeh Ghafouri-Fard, et al.
Published: (2021-11-01)

The Tumorigenic Effect of lncRNA AFAP1‐AS1 is Mediated by Translated Peptide ATMLP Under the Control of m6A Methylation
by: Hailong Pei, et al.
Published: (2023-05-01)

SP1-Induced Upregulation of LncRNA AFAP1-AS1 Promotes Tumor Progression in Triple-Negative Breast Cancer by Regulating mTOR Pathway
by: Fangyuan Li, et al.
Published: (2023-08-01)

Circ-AFAP1 promote clear cell renal cell carcinoma growth and angiogenesis by the Circ-AFAP1/miR-374b-3p/VEGFA signaling axis
by: Yuxi Ou, et al.
Published: (2022-02-01)

Increased lncRNA AFAP1‐AS1 expression predicts poor prognosis in gastric cancer: Evidence from published studies and followed up verification
by: Fujiao Duan, et al.
Published: (2023-02-01)

LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis
by: Zuo T, et al.
Published: (2023-01-01)

Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
by: Huaying Dong, et al.
Published: (2021-06-01)

Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer
by: Xu Han, et al.

Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
by: Huaying Dong, et al.
Published: (2022-06-01)

LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway
by: Deyao Shi, et al.
Published: (2019-08-01)

LncRNA AFAP-AS1 promotes anaplastic thyroid cancer progression by sponging miR-155-5p through ETS1/ERK pathway
by: MingLiang Ning, et al.
Published: (2021-01-01)

Correction to: LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway
by: Deyao Shi, et al.
Published: (2020-04-01)

Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancer
by: LI Zhiming , LONG Feng , HE Jianxin , HUANG Yong , SUN Shaokang
Published: (2021-04-01)

Long Noncoding RNA AFAP1-AS1 Is a Critical Regulator of Nasopharyngeal Carcinoma Tumorigenicity
by: Min Fang, et al.
Published: (2020-11-01)

AFAP1 Is a Novel Downstream Mediator of TGF-β1 for CCN2 Induction in Osteoblasts.
by: Youngjin Cho, et al.
Published: (2015-01-01)

Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway
by: Dongwei Dou, et al.
Published: (2020-10-01)

Hypoxia-induced AFAP1L1 regulates pathological neovascularization via the YAP-DLL4-NOTCH axis
by: Jun-Song Ren, et al.
Published: (2023-09-01)

LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2
by: Na Huang, et al.
Published: (2019-10-01)

Long Non-Coding RNAs ASB16-AS1 and AFAP1-AS1: Diagnostic, Prognostic Impact and Survival Analysis in Colorectal Cancer
by: Elabd NS, et al.
Published: (2022-08-01)

Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis
by: Bao Liu, et al.
Published: (2021-04-01)

Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc
by: Yu Zhong, et al.
Published: (2021-06-01)

Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab
by: Laure Thouvenin, et al.
Published: (2021-08-01)

Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells
by: Carolina D’Alesio, et al.
Published: (2017-11-01)

SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88
by: Huaying Dong, et al.
Published: (2018-08-01)

<i>ERBB2</i> mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer
by: Gaia Griguolo, et al.
Published: (2020-07-01)

Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non–small cell lung cancer cell proliferation by epigenetically repressing p21 expression
by: Dandan Yin, et al.
Published: (2018-05-01)

Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude mice
by: Xu-Bo Wu, et al.
Published: (2019-02-01)

Retraction Note: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88
by: Huaying Dong, et al.
Published: (2023-01-01)

ERBB1- and ERBB2-Positive Medullary Thyroid Carcinoma: A Case Report
by: Michele Minuto, et al.
Published: (2018-04-01)

Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity
by: Arik Durcker, et al.
Published: (2020-10-01)

AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
by: Kaiming Zhang, et al.
Published: (2018-11-01)

ERBB2D16 Expression in HER2 Positive Gastric Cancer Is Associated With Resistance to Trastuzumab
by: Shuo Wang, et al.
Published: (2022-04-01)

Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer
by: Xiaohui Zhang, et al.
Published: (2021-06-01)

Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.
by: Guangyuan Li, et al.
Published: (2014-01-01)